FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Composition",
  "id": "267224",
  "meta": {
    "versionId": "9",
    "lastUpdated": "2025-12-11T20:35:21.032Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-report"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "contained": [
    {
      "resourceType": "PractitionerRole",
      "id": "PointOfContact",
      "practitioner": {
        "display": "Chief Medical Officer"
      },
      "organization": {
        "display": "Eli Lilly and Company"
      },
      "contact": [
        {
          "telecom": [
            {
              "system": "email",
              "value": "ClinicalTrials.gov@lilly.com"
            }
          ]
        },
        {
          "telecom": [
            {
              "system": "phone",
              "value": "800-545-5979"
            }
          ]
        }
      ]
    }
  ],
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown": "An evidence report summarizing the Results Section of a ClinicalTrials.gov record entry"
    }
  ],
  "url": "https://fevir.net/resources/Composition/267224",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "267224",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "use": "official",
      "system": "https://clinicaltrials.gov",
      "value": "NCT03421379"
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "NCT03421379 Results Report",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "status": "final",
  "type": {
    "text": "EvidenceReport"
  },
  "category": [
    {
      "text": "ClinicalTrials.gov Study Results"
    }
  ],
  "subject": [
    {
      "reference": "ResearchStudy/267223",
      "type": "ResearchStudy",
      "identifier": {
        "type": {
          "text": "FEvIR Linking Identifier"
        },
        "system": "https://fevir.net/FLI",
        "value": "NCT03421379 FHIR Transform",
        "assigner": {
          "display": "Computable Publishing LLC"
        }
      },
      "display": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus"
    }
  ],
  "date": "2025-12-11T20:35:21.032Z",
  "useContext": [
    {
      "code": {
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
        "code": "program",
        "display": "Program"
      },
      "valueCodeableConcept": {
        "text": "ClinicalTrials.gov"
      }
    }
  ],
  "author": [
    {
      "display": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
    }
  ],
  "name": "NCT03421379_Results",
  "title": "Results Section for NCT03421379",
  "custodian": {
    "reference": "Organization/118079",
    "type": "Organization",
    "display": "Computable Publishing LLC"
  },
  "relatesTo": [
    {
      "type": "derived-from",
      "targetUri": "https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&max_rnk=1&fmt=JSON"
    },
    {
      "type": "cite-as",
      "targetMarkdown": "Results Section for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267224. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/267224. Computable resource at: https://fevir.net/resources/Composition/267224#json."
    }
  ],
  "section": [
    {
      "title": "Participant Flow Module",
      "code": {
        "text": "ParticipantFlowModule"
      },
      "entry": [
        {
          "reference": "Composition/399871",
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "NCT03421379-participant-flow-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "Participant Flow Report for NCT03421379"
        }
      ]
    },
    {
      "title": "Baseline Characteristics Module",
      "code": {
        "text": "BaselineCharacteristicsModule"
      },
      "entry": [
        {
          "reference": "Composition/399872",
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "NCT03421379-baseline-measure-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "Baseline Characteristics Report for NCT03421379"
        }
      ]
    },
    {
      "title": "Outcome Measures Module",
      "code": {
        "text": "OutcomeMeasuresModule"
      },
      "entry": [
        {
          "reference": "Composition/399873",
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "NCT03421379-outcome-measure-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "Outcome Measures Report for NCT03421379"
        }
      ]
    },
    {
      "title": "Adverse Events Module",
      "code": {
        "text": "AdverseEventsModule"
      },
      "entry": [
        {
          "reference": "Composition/399874",
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "NCT03421379-adverse-events-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "Adverse Events Report for NCT03421379"
        }
      ]
    },
    {
      "title": "More Info Module",
      "code": {
        "text": "MoreInfoModule"
      },
      "section": [
        {
          "title": "Certain Agreement",
          "code": {
            "text": "CertainAgreement"
          },
          "entry": [
            {
              "display": "AgreementPISponsorEmployee False"
            },
            {
              "display": "AgreementRestrictionType GT60"
            },
            {
              "display": "AgreementRestrictiveAgreement True"
            }
          ]
        },
        {
          "title": "Point Of Contact",
          "code": {
            "text": "PointOfContact"
          },
          "text": {
            "status": "generated",
            "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Chief Medical Officer, Eli Lilly and Company</div>"
          },
          "entry": [
            {
              "reference": "#PointOfContact",
              "type": "PractitionerRole",
              "display": "Chief Medical Officer, Eli Lilly and Company"
            }
          ]
        }
      ]
    }
  ]
}